Antibody-Drug Conjugates in Bladder Cancer
Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against a specific...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publishing
2018-07-01
|
| Schriftenreihe: | Bladder Cancer |
| Online-Zugang: | https://doi.org/10.3233/BLC-180169 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|